Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations – An Implementation Research Protocol
Abstract
In Europe, cervical cancer (CC) is the third most common gynaecologic cancer, and the second among women under the age of 45. CC screening uptake is highly variable across the region, and especially low among vulnerable groups. Current evidence suggests that HPV (Human Papilloma Virus) vaccination benefits women beyond traditional adolescent vaccination age groups, and so the HPV-FASTER approach has been proposed as a strategy to accelerate the elimination of CC in Europe. The HPV-FASTER-Implement implementation research project aims to evaluate strategies that integrate HPVbased screening with concomitant HPV vaccination (HPV-FASTER approach) for vulnerable groups aged 25-45 years, including migrants and sex workers in Spain and Sweden, women living with HIV and transgender men in Denmark, incarcerated women in Romania, and women living in deprived areas in France. Methods: To assess the capacity of health systems to deliver combined HPV vaccination and HPV-based screening, we adapted the Cervical Cancer Screening Service Availability and Readiness Assessment (CervScreen-SARA) protocol and tools, considering also the WHO Effective Vaccine Management tool. This implementation research protocol includes three components: a desk review of CC screening and vaccination guidelines, and policies currently in place; screening, colposcopy, and vaccination services facility visits; and interviews with key meso-and macro-level stakeholders. Triangulation of the information allows the identification of strengths and areas of improvement in implementing the HPV-FASTER approach. Conclusions: This implementation research protocol offers a structured approach to assess the readiness of health systems to deliver combined HPV vaccination and HPV-based CC screening to vulnerable populations, and will allow the tailoring of strategies to strengthen CC prevention services.
Related
- Assessment of vaccination competency among health workers in health facilities in East Wollega, Oromia, Western Ethiopia: An observational study
- From Monogenic Variants to Polygenic Risk Scores in Inherited Cardiomyopathies: Clinical Utility, Ancestry Gaps, and Future Implementation in Arab Populations
- Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study
- Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
- Gut microbiota composition of India’s Baiga tribe: Insights from an indigenous particularly vulnerable tribal group
BibTeX
@article{mosquera2026assessing,
title = {{Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations – An Implementation Research Protocol}},
author = {Isabel Mosquera and Anna Tisler and Arianis Tatiana Ramirez and K Miriam Elfstrom and Joakim Dillner and Claudia Robles and Paula Peremiquel-Trillas and Xavier Bosch and Andrea Gini and Iacopo Baussano and Marc Bardou and Amir Hassine and Carine Franc and Gwen Menvielle and Mette Tranberg and Ann-Line Axelsen and Pia Kirkegaard and Berit Andersen and Lone Kjeld Petersen and Dorte Glintborg and Raquel Martin-Iguacel and Isik Somuncu Johansen and Louise Lehmann Christensen and Sanne Jespersen and Eva Hauge and Ioana Rotar and Daniel Muresan and Adriana Baban and Diana Taut and Niamh M Redmond and Partha Basu},
journal = {Cancer Control: Journal of the Moffitt Cancer Center},
year = {2026},
month = sep,
doi = {10.1177/10732748261475365},
url = {https://hal.science/hal-05738803v1},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations – An Implementation Research Protocol
AU - Isabel Mosquera
AU - Anna Tisler
AU - Arianis Tatiana Ramirez
AU - K Miriam Elfstrom
AU - Joakim Dillner
AU - Claudia Robles
AU - Paula Peremiquel-Trillas
AU - Xavier Bosch
AU - Andrea Gini
AU - Iacopo Baussano
AU - Marc Bardou
AU - Amir Hassine
AU - Carine Franc
AU - Gwen Menvielle
AU - Mette Tranberg
AU - Ann-Line Axelsen
AU - Pia Kirkegaard
AU - Berit Andersen
AU - Lone Kjeld Petersen
AU - Dorte Glintborg
AU - Raquel Martin-Iguacel
AU - Isik Somuncu Johansen
AU - Louise Lehmann Christensen
AU - Sanne Jespersen
AU - Eva Hauge
AU - Ioana Rotar
AU - Daniel Muresan
AU - Adriana Baban
AU - Diana Taut
AU - Niamh M Redmond
AU - Partha Basu
PY - 2026
DA - 2026/09/02
JO - Cancer Control: Journal of the Moffitt Cancer Center
DO - 10.1177/10732748261475365
UR - https://hal.science/hal-05738803v1
AB - In Europe, cervical cancer (CC) is the third most common gynaecologic cancer, and the second among women under the age of 45. CC screening uptake is highly variable across the region, and especially low among vulnerable groups. Current evidence suggests that HPV (Human Papilloma Virus) vaccination benefits women beyond traditional adolescent vaccination age groups, and so the HPV-FASTER approach has been proposed as a strategy to accelerate the elimination of CC in Europe. The HPV-FASTER-Implement implementation research project aims to evaluate strategies that integrate HPVbased screening with concomitant HPV vaccination (HPV-FASTER approach) for vulnerable groups aged 25-45 years, including migrants and sex workers in Spain and Sweden, women living with HIV and transgender men in Denmark, incarcerated women in Romania, and women living in deprived areas in France. Methods: To assess the capacity of health systems to deliver combined HPV vaccination and HPV-based screening, we adapted the Cervical Cancer Screening Service Availability and Readiness Assessment (CervScreen-SARA) protocol and tools, considering also the WHO Effective Vaccine Management tool. This implementation research protocol includes three components: a desk review of CC screening and vaccination guidelines, and policies currently in place; screening, colposcopy, and vaccination services facility visits; and interviews with key meso-and macro-level stakeholders. Triangulation of the information allows the identification of strengths and areas of improvement in implementing the HPV-FASTER approach. Conclusions: This implementation research protocol offers a structured approach to assess the readiness of health systems to deliver combined HPV vaccination and HPV-based CC screening to vulnerable populations, and will allow the tailoring of strategies to strengthen CC prevention services.
SN - 1073-2748
SN - 1526-2359
ER -